BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2272039)

  • 1. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients.
    Unger C; Peukert M; Sindermann H; Hilgard P; Nagel G; Eibl H
    Cancer Treat Rev; 1990 Sep; 17(2-3):243-6. PubMed ID: 2272039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexadecylphosphocholine (D 18506) in the topical treatment of skin metastases: a phase-I trial.
    Unger C; Eibl H; Breiser A; von Heyden HW; Engel J; Hilgard P; Sindermann H; Peukert M; Nagel GA
    Onkologie; 1988 Dec; 11(6):295-6. PubMed ID: 3071766
    [No Abstract]   [Full Text] [Related]  

  • 3. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients.
    Unger C; Sindermann H; Peukert M; Hilgard P; Engel J; Eibl H
    Prog Exp Tumor Res; 1992; 34():153-9. PubMed ID: 1438798
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of cutaneous metastases of a squamous cell carcinoma of the leg with topical miltefosine].
    Mahieu-Renard L; Richard MA; Dales JP; Buscaylet S; Lagrassa S; Grob JJ
    Ann Dermatol Venereol; 2005 Apr; 132(4):346-8. PubMed ID: 15886562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer.
    Leonard R; Hardy J; van Tienhoven G; Houston S; Simmonds P; David M; Mansi J
    J Clin Oncol; 2001 Nov; 19(21):4150-9. PubMed ID: 11689583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients.
    Smorenburg CH; Seynaeve C; Bontenbal M; Planting AS; Sindermann H; Verweij J
    Anticancer Drugs; 2000 Nov; 11(10):825-8. PubMed ID: 11142690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer.
    Terwogt JM; Mandjes IA; Sindermann H; Beijnen JH; ten Bokkel Huinink WW
    Br J Cancer; 1999 Mar; 79(7-8):1158-61. PubMed ID: 10098751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma.
    Clive S; Gardiner J; Leonard RC
    Cancer Chemother Pharmacol; 1999; 44 Suppl():S29-30. PubMed ID: 10602908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miltefosine in recurrent cutaneous breast cancer.
    Clive S; Leonard RC
    Lancet; 1997 Mar; 349(9052):621-2. PubMed ID: 9057742
    [No Abstract]   [Full Text] [Related]  

  • 10. Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo.
    Unger C; Damenz W; Fleer EA; Kim DJ; Breiser A; Hilgard P; Engel J; Nagel G; Eibl H
    Acta Oncol; 1989; 28(2):213-7. PubMed ID: 2736110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[Treatment with Miltex for metastatic skin lesions in breast cancer] ].
    Moĭseenko VM; Orlova RV; Ermakova NA; Protsenko SA
    Vopr Onkol; 2000; 46(5):600-3. PubMed ID: 11202195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas.
    Dummer R; Röger J; Vogt T; Becker J; Hefner H; Sindermann H; Burg G
    Prog Exp Tumor Res; 1992; 34():160-9. PubMed ID: 1438799
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study.
    Dummer R; Krasovec M; Röger J; Sindermann H; Burg G
    J Am Acad Dermatol; 1993 Dec; 29(6):963-70. PubMed ID: 8245262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miltefosine: new preparation. Solution for cutaneous application.
    Prescrire Int; 1998 Feb; 7(33):5-6. PubMed ID: 10183390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loco-regional control of cutaneous metastases of malignant melanoma by treatment with miltefosine (Miltex).
    Ragnarsson-Olding B; Djureen-Mårtensson E; Månsson-Brahme E; Hansson J
    Acta Oncol; 2005; 44(7):773-7. PubMed ID: 16227173
    [No Abstract]   [Full Text] [Related]  

  • 16. Hexadecylphosphocholine: a new and selective antitumor drug.
    Eibl H; Unger C
    Cancer Treat Rev; 1990 Sep; 17(2-3):233-42. PubMed ID: 2272038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexadecylphosphocholine: preclinical and the first clinical results of a new antitumor drug.
    Unger C; Eibl H
    Lipids; 1991 Dec; 26(12):1412-7. PubMed ID: 1819743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple cutaneous plasmocytoma treated with topical applications of miltefosine].
    Viseux V; Schoenlaub P; Danhier S; Vilque JP; Plantin P
    Ann Dermatol Venereol; 2004 Feb; 131(2):204-5. PubMed ID: 15026752
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase-II study of Navelbine in advanced breast cancer.
    Canobbio L; Boccardo F; Pastorino G; Brema F; Martini C; Resasco M; Santi L
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):33-6. PubMed ID: 2711204
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticancer therapy for breast cancer patients with skin metastases refractory to conventional treatments.
    Varol U; Yildiz I; Alacacioglu A; Uslu R
    Asian Pac J Cancer Prev; 2014; 15(4):1885-7. PubMed ID: 24641425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.